1min snip

Economist Podcasts cover image

Money Talks: Why weight-loss drugs will reshape the world

Economist Podcasts

NOTE

Revolution in Weight Loss Treatments

The emergence of a new class of weight loss drugs known as GLP1s is revolutionary due to their effectiveness and minimal side effects. However, despite their high cost, these drugs have proven to be incredibly profitable for companies like Novo Nordisk and Eli Lilly. This success has elevated Novo Nordisk to become Europe's most valuable firm and sparked speculation that these companies could eventually reach trillion-dollar market valuations.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode